VEGFA and breast cancer: In addition, miR-100 delivered by MSC-Exos was able to inhibit angiogenesis in vitro by regulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells, thereby influencing the behavior of breast cancer cells (Pakravan et al., 2017).